Bayer has announced positive results from a phase I trial of bemdaneprocel, an investigational therapy […]
CDSCO Panel Asks Akum Pharma to Present Rationality for Combining Lobeglitazone, Sitagliptin FDC
A panel of experts from the Central Drug Standard Control Organization (CDSCO) has asked Akum […]
Cancer Drugs Show Promise in Fight Against Malaria
Researchers are focusing on cancer drugs to fight against malaria, a mosquito-borne disease that kills […]
Trastuzumab Price Reduced by Glenmark, Making Drug More Affordable
Glenmark Pharmaceuticals Ltd. on Thursday announced that it has slashed the price of its breast […]
NPPA Fixes Prices of 23 Drug Formulations to Make Drugs More Affordable
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 23 drug formulations, […]
Novo Nordisk Announces FDA Approval of Label Update for Rybelsus (semaglutide) Allowing Use as a First-Line Option for Adults with Type 2 Diabetes
The U.S. Food and Drug Administration (FDA) has approved a label update for Rybelsus (semaglutide) tablets […]
Generic Drugs vs. Brand: What You Need to Know
One of the most common questions I get as a pharmacist is, “Are generics really […]
Six sigma in Pharmaceutical Manufacturing Industry
Six sigma is delivering business excellence, higher customer satisfaction, and superior profits by dramatically improving […]
Government Takes Action to Protect Public Health by Banning 14 FDC Drugs
Expert Committee Recommends Ban on 14 FDC Drugs in India The Indian government has banned […]
WHO Flags Seven Indian-Made Medicines as Toxic
The World Health Organization (WHO) has flagged seven medicines manufactured in India as toxic. The […]
Roche’s Columvi Receives FDA Approval for Relapsed or Refractory Large B-Cell Lymphoma
Roche’s Columvi (glofitamab) has been granted accelerated approval by the FDA for the treatment of […]
India’s Top 5 Pharma Stocks to Watch in 2023
The Indian pharmaceutical industry is one of the fastest growing in the world. In 2022, […]